“Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients With COVID -19”. Journal of Pharmaceutical Negative Results, vol. 13, no. 2, June 2022, pp. 82-86, https://pnrjournal.com/index.php/home/article/view/199.